Illumina has launched the TruSeq Amplicon — Cancer Panel, a multiplexed panel for sequencing hundreds of cancer loci.

The company said that the panel can detect mutations below five percent frequency, even in difficult samples such as formalin-fixed, paraffin-embedded tumor samples.

The panel is now available for order now and will begin shipping in April.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.